TCR2 Therapeutics Competitors and Similar CompaniesClear all
TCR2 Therapeutics's competitors and similar companies include MetaboGen AB and Metabolon.
 TCR2 Therapeutics TCR2 Therapeutics is a discovery-stage pharmaceutical company focused on engineering T cells for cancer therapy. |  MetaboGen AB As a pioneering company, MetaboGen is addressing the microbiome to understand health and disease. |  Metabolon Global leader in metabolomics for precision medicine, biomarker discovery, and advancing pharma & life sciences research. | |
Founding Date | Founding Date 2015 | Founding Date 2011 | Founding Date 2000 |
Type | Type Subsidiary | Type Private | Type Private |
Tags | |||
Locations | Locations Cambridge, US HQ | Locations Mölndal, SE HQ Stockholm, SE | Locations Morrisville, US HQ Hallbergmoos, DE München, DE |
Employees | Employees 445% increase | Employees 1 | Employees 1911% increase |
Funding | |||
Total funding raised | Total funding raised $ 173.3m | Total funding raised N/A | Total funding raised $ 95.4m |
For sources of this data, please see the company profile
View Company Profiles
MetaboGen AB
HQ
Mölndal, SE
Employees
1
As a pioneering company, MetaboGen is addressing the microbiome to understand health and disease.
View companyMetabolon
HQ
Morrisville, US
Employees
191↑ 1% increase
Global leader in metabolomics for precision medicine, biomarker discovery, and advancing pharma & life sciences research.
View company